scholarly journals Efficacy of HER2-targeted therapy in metastatic breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors

The Breast ◽  
2013 ◽  
Vol 22 (1) ◽  
pp. 1-12 ◽  
Author(s):  
Dorte L. Nielsen ◽  
Iben Kümler ◽  
Jesper A.E. Palshof ◽  
Michael Andersson
Keyword(s):  
Breast Cancer ◽  
Monoclonal Antibodies ◽  
Metastatic Breast Cancer ◽  
Targeted Therapy ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitors ◽  
Kinase Inhibitors ◽  
Metastatic Breast

scholarly journals Significance of Tyrosine Kinase Inhibitors in the Treatment of Metastatic Breast Cancer

Breast Care ◽  
2009 ◽  
Vol 4 (6) ◽  
pp. 373-378 ◽  
Author(s):  
Christoph Mundhenke ◽  
Alexander Strauss ◽  
Christian Schem
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitors ◽  
Kinase Inhibitors ◽  
Metastatic Breast

scholarly journals Anti-EGFR monoclonal antibodies and EGFR tyrosine kinase inhibitors as combination therapy for triple-negative breast cancer

Oncotarget ◽  
2016 ◽  
Vol 7 (45) ◽  
pp. 73618-73637 ◽  
Author(s):  
Abderrahim El Guerrab ◽  
Mahchid Bamdad ◽  
Fabrice Kwiatkowski ◽  
Yves-Jean Bignon ◽  
Frédérique Penault-Llorca ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Monoclonal Antibodies ◽  
Combination Therapy ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitors ◽  
Triple Negative Breast Cancer ◽  
Kinase Inhibitors ◽  
Triple Negative ◽  
Egfr Tyrosine Kinase ◽  
Egfr Tyrosine Kinase Inhibitors
Sign in / Sign up

Export Citation Format

Share Document